Hepatocyte growth factor activator (HGFA) is an enzyme that plays a pivotal role in the activation of hepatocyte growth factor (HGF), which is a multifunctional cytokine involved in various cellular processes, including cell proliferation, motility, and morphogenesis. HGFA itself is synthesized as an inactive proenzyme and requires proteolytic cleavage to become active. HGFA activators are a class of compounds that facilitate the conversion of pro-HGFA to its active form or enhance its enzymatic activity towards the precursor form of HGF, known as pro-HGF.
Direct HGFA activators can interact with the enzyme itself, possibly by binding to specific domains of the protein that are involved in the activation process. Such activators induce a conformational change that exposes the enzyme's active site more effectively or stabilizes the enzyme in an active configuration. By altering the structure of HGFA directly, these compounds would increase its activity, leading to enhanced cleavage of pro-HGF to HGF. Indirect HGFA activators function through various mechanisms that ultimately lead to an increase in HGFA activity. They enhance the transcription and translation of HGFA, leading to higher levels of the enzyme within the cell. Other indirect activators inhibit the natural inhibitors of HGFA, thereby increasing the net enzymatic activity. Additionally, compounds that modulate the cellular localization of HGFA to ensure optimal interaction with pro-HGF could also be considered as indirect activators.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of Protein Kinase C (PKC), which is known to phosphorylate and activate MET. This could indirectly promote HGFA activation. | ||||||
Nicotinamide | 98-92-0 | sc-208096 sc-208096A sc-208096B sc-208096C | 100 g 250 g 1 kg 5 kg | $44.00 $66.00 $204.00 $831.00 | 6 | |
Nicotinamide is involved in the provision of NAD+, necessary for cell survival and proliferation. This could indirectly impact the synthesis and secretion of HGFA. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an activator of adenylate cyclase, leading to increased cAMP levels. cAMP can activate the PKA pathway, which then can phosphorylate and activate MET, possibly leading to increased HGFA activity. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By preventing PI3K activation, it reduces negative feedback on the MET pathway, which could lead to increased HGFA activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor. By inhibiting mTOR, it can reduce negative feedback on the MET pathway, potentially leading to increased HGFA activity. | ||||||
Akt Inhibitor IV | 681281-88-9 | sc-203809 sc-203809A | 5 mg 25 mg | $176.00 $709.00 | 42 | |
This inhibitor prevents Akt phosphorylation, thereby reducing negative feedback on the MET pathway, potentially promoting HGFA activation. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a MEK inhibitor that can reduce ERK pathway activation, thereby reducing negative feedback on the MET pathway, potentially leading to increased HGFA activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is a JNK inhibitor. By inhibiting JNK, it can reduce stress-induced apoptosis, potentially promoting cell survival and thus indirectly influencing HGFA activity. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor. By inhibiting p38 MAPK, it can reduce stress-induced apoptosis, potentially promoting cell survival and thus indirectly influencing HGFA activity. | ||||||